133 related articles for article (PubMed ID: 35654390)
21. Resolving the cofactor-binding site in the proline biosynthetic enzyme human pyrroline-5-carboxylate reductase 1.
Christensen EM; Patel SM; Korasick DA; Campbell AC; Krause KL; Becker DF; Tanner JJ
J Biol Chem; 2017 Apr; 292(17):7233-7243. PubMed ID: 28258219
[TBL] [Abstract][Full Text] [Related]
22. Proline synthesis through PYCR1 is required to support cancer cell proliferation and survival in oxygen-limiting conditions.
Westbrook RL; Bridges E; Roberts J; Escribano-Gonzalez C; Eales KL; Vettore LA; Walker PD; Vera-Siguenza E; Rana H; Cuozzo F; Eskla KL; Vellama H; Shaaban A; Nixon C; Luuk H; Lavery GG; Hodson DJ; Harris AL; Tennant DA
Cell Rep; 2022 Feb; 38(5):110320. PubMed ID: 35108535
[TBL] [Abstract][Full Text] [Related]
23. DJ-1 cooperates with PYCR1 in cell protection against oxidative stress.
Yasuda T; Kaji Y; Agatsuma T; Niki T; Arisawa M; Shuto S; Ariga H; Iguchi-Ariga SM
Biochem Biophys Res Commun; 2013 Jun; 436(2):289-94. PubMed ID: 23743200
[TBL] [Abstract][Full Text] [Related]
24. Kindlin-2 links mechano-environment to proline synthesis and tumor growth.
Guo L; Cui C; Zhang K; Wang J; Wang Y; Lu Y; Chen K; Yuan J; Xiao G; Tang B; Sun Y; Wu C
Nat Commun; 2019 Feb; 10(1):845. PubMed ID: 30783087
[TBL] [Abstract][Full Text] [Related]
25.
Bae DH; Kim HJ; Yoon BH; Park JL; Kim M; Kim SK; Kim SY; Lee SI; Song KS; Kim YS
Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649810
[TBL] [Abstract][Full Text] [Related]
26. Zebrafish Carrying
Liang ST; Audira G; Juniardi S; Chen JR; Lai YH; Du ZC; Lin DS; Hsiao CD
Cells; 2019 May; 8(5):. PubMed ID: 31091804
[TBL] [Abstract][Full Text] [Related]
27. PYCR1 knockdown inhibits the proliferation, migration, and invasion by affecting JAK/STAT signaling pathway in lung adenocarcinoma.
Gao Y; Luo L; Xie Y; Zhao Y; Yao J; Liu X
Mol Carcinog; 2020 May; 59(5):503-511. PubMed ID: 32133692
[TBL] [Abstract][Full Text] [Related]
28. Hypomethylation-activated cancer-testis gene LIN28B promotes cell proliferation and metastasis in gastric cancer.
Xu J; Zhou Y; Yang J; Gu Y; Zhang E; Yuan W; Wang C; Jin G; Ma H; Hu Z
Gene; 2022 Mar; 813():146115. PubMed ID: 34902508
[TBL] [Abstract][Full Text] [Related]
29. Clusterin and Pycr1 alterations associate with strain and model differences in susceptibility to experimental pancreatitis.
Iyer S; Park MJ; Moons D; Kwan R; Liao J; Liu L; Omary MB
Biochem Biophys Res Commun; 2017 Jan; 482(4):1346-1352. PubMed ID: 27939882
[TBL] [Abstract][Full Text] [Related]
30. PYCR1 interference inhibits cell growth and survival via c-Jun N-terminal kinase/insulin receptor substrate 1 (JNK/IRS1) pathway in hepatocellular cancer.
Zhuang J; Song Y; Ye Y; He S; Ma X; Zhang M; Ni J; Wang J; Xia W
J Transl Med; 2019 Oct; 17(1):343. PubMed ID: 31619254
[TBL] [Abstract][Full Text] [Related]
31. Defect in proline synthesis: pyrroline-5-carboxylate reductase 1 deficiency leads to a complex clinical phenotype with collagen and elastin abnormalities.
Kretz R; Bozorgmehr B; Kariminejad MH; Rohrbach M; Hausser I; Baumer A; Baumgartner M; Giunta C; Kariminejad A; Häberle J
J Inherit Metab Dis; 2011 Jun; 34(3):731-9. PubMed ID: 21487760
[TBL] [Abstract][Full Text] [Related]
32. Novel Fragment Inhibitors of PYCR1 from Docking-Guided X-ray Crystallography.
Meeks KR; Ji J; Protopopov MV; Tarkhanova OO; Moroz YS; Tanner JJ
J Chem Inf Model; 2024 Mar; 64(5):1704-1718. PubMed ID: 38411104
[TBL] [Abstract][Full Text] [Related]
33. MiR-1207-5p targets PYCR1 to inhibit the progression of prostate cancer.
Xu H; He Y; Lin L; Li M; Zhou Z; Yang Y
Biochem Biophys Res Commun; 2021 Oct; 575():56-64. PubMed ID: 34461437
[TBL] [Abstract][Full Text] [Related]
34. A fragment-like approach to PYCR1 inhibition.
Milne K; Sun J; Zaal EA; Mowat J; Celie PHN; Fish A; Berkers CR; Forlani G; Loayza-Puch F; Jamieson C; Agami R
Bioorg Med Chem Lett; 2019 Sep; 29(18):2626-2631. PubMed ID: 31362921
[TBL] [Abstract][Full Text] [Related]
35. Pyrroline-5-carboxylate reductase 1 promotes proliferation and inhibits apoptosis in non-small cell lung cancer.
Cai F; Miao Y; Liu C; Wu T; Shen S; Su X; Shi Y
Oncol Lett; 2018 Jan; 15(1):731-740. PubMed ID: 29403556
[TBL] [Abstract][Full Text] [Related]
36. Promoter methylation of RNF180 is associated with H.pylori infection and serves as a marker for gastric cancer and atrophic gastritis.
Han F; Sun LP; Liu S; Xu Q; Liang QY; Zhang Z; Cao HC; Yu J; Fan DM; Nie YZ; Wu KC; Yuan Y
Oncotarget; 2016 Apr; 7(17):24800-9. PubMed ID: 27050149
[TBL] [Abstract][Full Text] [Related]
37. Genotype-phenotype spectrum of PYCR1-related autosomal recessive cutis laxa.
Dimopoulou A; Fischer B; Gardeitchik T; Schröter P; Kayserili H; Schlack C; Li Y; Brum JM; Barisic I; Castori M; Spaich C; Fletcher E; Mahayri Z; Bhat M; Girisha KM; Lachlan K; Johnson D; Phadke S; Gupta N; Simandlova M; Kabra M; David A; Nijtmans L; Chitayat D; Tuysuz B; Brancati F; Mundlos S; Van Maldergem L; Morava E; Wollnik B; Kornak U
Mol Genet Metab; 2013 Nov; 110(3):352-61. PubMed ID: 24035636
[TBL] [Abstract][Full Text] [Related]
38. PYCR1 promotes bladder cancer by affecting the Akt/Wnt/β-catenin signaling.
Du S; Sui Y; Ren W; Zhou J; Du C
J Bioenerg Biomembr; 2021 Apr; 53(2):247-258. PubMed ID: 33689096
[TBL] [Abstract][Full Text] [Related]
39. Down-regulation of dual-specificity phosphatase 5 in gastric cancer by promoter CpG island hypermethylation and its potential role in carcinogenesis.
Shin SH; Park SY; Kang GH
Am J Pathol; 2013 Apr; 182(4):1275-85. PubMed ID: 23402999
[TBL] [Abstract][Full Text] [Related]
40. Increased PYCR1 mRNA predicts poor prognosis in kidney adenocarcinoma: A study based on TCGA database.
Zhang T; Liu Y; Liu W; Li Q; Hou W; Huang Y; Lv P; Meng L; Li Y; Jia Y; Liu X; Zuo Z
Medicine (Baltimore); 2021 Sep; 100(38):e27145. PubMed ID: 34559102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
